USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ASH ACCESS TECHNOLOGY, INC.
Address: 3601 SAGAMORE PARKWAY N
STE B
LAFAYETTE, IN 47904 5033
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $617,030.00 11
SBIR Phase II $4,149,430.00 4

Award List:

MINIATURIZED HEMO-AND PERITONEAL DIALYSIS MACHINE

Award Year / Program / Phase: 1984 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen R. Ash , Director
Award Amount: $48,030.00

MINIATURIZED HEMO-AND PERITONEAL DIALYSIS MACHINE

Award Year / Program / Phase: 1986 / SBIR / Phase II
Agency: HHS
Principal Investigator: Stephen R. Ash , Director
Award Amount: $500,000.00
Abstract:
The objective of this research project is to produce a portable, miniaturized dialysis machine which is simple, safe, and symptom-free in operation. this dialysis machine should allow the average hemo-or peritoneal dialysis patient to perform dialysis by himself at home, unassisted. the machine will… More

IMPLANTABLE HOLLOW FIBER GLUCOSE SENSOR

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency: HHS
Principal Investigator: Elsa Janle-swain , Principal Investigator
Award Amount: $49,000.00

IMPLANTABLE HOLLOW FIBER GLUCOSE SENSOR

Award Year / Program / Phase: 1987 / SBIR / Phase II
Agency: HHS
Principal Investigator: Elsa Janle-swain , Principal Investigator
Award Amount: $258,000.00
Abstract:
Ash medical systems, inc. is developing two closely related devices that will improve home and hospital monitoring of glucose for diabetics. the common element of both devices is a fiber that is implanted subcutaneously. a negative pressure is applied to this fiber to withdraw tissue fluid. in the… More

A NEW SORBENT SYSTEM FOR HEMODIALYSIS TREATMENT

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen r ash md
Award Amount: $50,000.00
Abstract:
Ash medical systems, inc. has developed a new sorbent-based,single-access hemodialysis machine that is safe, simple, and portable. the biologic-hd currently uses a plate dialyzer to actively pump blood while dialyzing the blood and a redy hisorb column to regenerate dialysate. previous research has… More

INDWELLING FISTULA ACCESS DEVICE (IFAD) FOR HEMODIALYSIS

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen r ash md
Award Amount: $50,000.00
Abstract:
Effective hemodialysis requires a blood flow of 250 to 300 ml/minute. the usual method for obtaining this blood isto place two large needles into a fistula (arterialized vein) or a graft (ptfe conduit between artery and vein). both needles are removed at the end of each treatment. the objective of… More

THE BIOLOGIC-PD; A NIGHTTIME PERITONEAL CYCLER

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
The goal of this project is to adapt an existent single-access hemodialysis machine, the biologic-hd(tm), to perform nighttime peritoneal dialysis with high dialysate volumes. a disposable package on this machine will include a 30 liter bag which includes dry premeasured amounts of nac1, nahc03,… More

BIOLOGIC - DC SYSTEM FOR REMOVING CO2 FROM BLOOD

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
The goal of this project is to develop an extracorporeal device to revove large amounts of carbon dioxide (co2) from a relatively small flow rate of blood. this decarboxylator device could help support patients when respirator fail to remove sufficient co2 or be used in placeof respirators in… More

UREA MONITORING DURING DIALYSIS WITH THE BIOLOGIC-HD

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
We have developed a dialysis system which is simple, safe, and portable. the biologic-hd system is a single access, sorbent based dialysis system with recently developed monitors to determine: total weight removal, blood flow rate, clotting of the dialyzer, and column saturation (a continually… More

SUBCUTANEOUS INFUSION ACCESS DEVICE

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Continuous subcutaneous insulin infusion has become an important method of treating insulin dependent diabetics because the better glucose control achievable by this method could potentially reduce the morbidity and mortality associated with the disease. current subcutaneous access is via a needle… More

MONITORING DRUG THERAPY THROUGH SMARTCHART

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Adverse drug interactions and toxicities are common in elderly patients. smartchart is a program that allows nurses and physicians to enter real-time clinical data into pc's from the bedside. the paper chart is generated througha microcomputer rather than by pen or dictation. during phase i,… More

Waterless Dialysis System

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: Stephen R. Ash, MD, Chairman, Director of R&D
Award Amount: $70,000.00
Abstract:
"Early and effective hemodialysis can decrease mortality of trauma patients with acute renal failure, but current technology is not easily deployed in the field or during transit of patients. The "Redy" machine using the Sorb column was portable andutilized only 6 liters of water but did not make… More

Waterless Dialysis System

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency / Branch: DOD / ARMY
Principal Investigator: Stephen Ash, Chairman, Director of R&D
Award Amount: $730,000.00
Abstract:
Early and effective hemodialysis can decrease mortality of trauma patients with acute renal failure. Unfortunately, current technology is not easily deployed in the field or during transport of patients. The Sorbent Hemodialysis (SHD) System now beingdeveloped using technology from Ash Medical… More

MethLock vs. heparin as dialysis catheter lock

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen R. Ash
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Currently about 25% of patients on hemodialysis therapy for End Stage Renal Disease (ESRD) receives dialysis through tunneled central venous catheters for dialysis (CVCD). The standard anticoagulant lock for these catheters is heparin, which has no antibacterial… More

MethLock vs. heparin as dialysis catheter lock

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Stephen R. Ash
Award Amount: $2,661,430.00
Abstract:
Not avaiable.